Yeah, ClosetInvestor loves to point to the companies shortcomings any opportunity s/he gets. I think discussing topics of that nature are best done in more private and discreet groups than a message board infiltrated by shorts and bashers looking for fodder for their Tweets and articles, but CI likes to just air out the laundry for all to see namely because I think he's here to fuel any negativity that can be mustered up. I haven't invested in any perfectly managed companies, but I am invested in companies with products the world needs and wants, CYDY very much included. A posters who constantly gripe about management in a public forum, where no real solutions or progress can be made by the company directly, is just either a wolf in sheep's clothing or someone who is so emotionally weak that s/he needs to vent to anonymous strangers because they can't handle red days/faster ROI.

The call provided encouraging updates on the rolling submission process for the BLA to make it more efficient, more updates on cancer than expected, clarity on international EUA processes, the mortality total in CD12, and it was inspiring to hear the testimonials of patients who have had their quality of life improved by Leronlimab (we aren't only here to make $$, are we?). And it's always appreciated to get to hear from and correspond with the management directly. If shareholders only want Covid or Nasdaq updates, they probably shouldn't comment about the nature of these holistic updates from these calls and just wait for PR.